ALERT:

Clinical Trial

Urothelial Cancer, Bladder Cancer, Kidney Cancer Clinical Trial 2002-061

[LCID Study Number: 2002-061]

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney

The purpose of this study is to determine if the analysis of the DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney.

Disease/Condition: Urothelial Cancer, Bladder Cancer, Kidney Cancer

Department: Cell and Molecular Biology Research Laboratory

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: linda.m.topjian@lahey.org

Primary Contact Phone: 781-744-8711

Clinical Trial Details

View NCT ID 872495 on ClinicalTrials.gov

Protocol #: 2002-061

Principal Investigator(s): Kimberly Rieger-Christ

Study Coordinator(s): Linda Topjian

Trial Phase: Sponsor Initiated Study Observational